11. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis. (November 2015) Authors: Clayton, Anita H.; Hwang, Eunhee; Kornstein, Susan G.; Tourian, Karen A.; Cheng, Ru-fong; Abraham, Lucy; Mele, Linda; Boucher, Matthieu Journal: International clinical psychopharmacology Issue: Volume 30:Number 6(2015:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis. (26th March 2015) Authors: Thase, Michael E.; Fayyad, Rana; Cheng, Ru-fong J.; Guico-Pabia, Christine J.; Sporn, Jonathan; Boucher, Matthieu; Tourian, Karen A. Journal: Current medical research and opinion Issue: Volume 31:Number 4(2015:Apr.) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis. (March 2020) Authors: Katzman, Martin A; Wang, Xuemei; Wajsbrot, Dalia B; Boucher, Matthieu Journal: Journal of psychopharmacology Issue: Volume 34:Number 3(2020) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline. Issue 2 (April 2017) Authors: Mosca, Daniel; Zhang, Min; Prieto, Rita; Boucher, Matthieu Journal: Journal of clinical psychopharmacology Issue: Volume 37:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study. (2nd December 2019) Authors: McIntyre, Roger S.; Prieto, Rita; Schepman, Patricia; Yeh, Yu-Chen; Boucher, Matthieu; Shelbaya, Ahmed; Chambers, Richard; Gao, Xin; Pappadopulos, Elizabeth Journal: Current medical research and opinion Issue: Volume 35:Number 12(2019) Page Start: 2169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study. (September 2017) Authors: Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; Tsuboi, Takashi; Asami, Yuko; Pappadopulos, Elizabeth; Zhang, Min; Boucher, Matthieu; Kornstein, Susan Journal: International clinical psychopharmacology Issue: Volume 32:Number 5(2017:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder. (7th June 2020) Authors: Soares, Claudio N.; Wajsbrot, Dalia B.; Boucher, Matthieu Journal: CNS spectrums Issue: Volume 25:Number 3(2020) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder. (26th February 2014) Authors: Soares, Claudio N.; Endicott, Jean; Boucher, Matthieu; Fayyad, Rana S.; Guico-Pabia, Christine J. Journal: CNS spectrums Issue: Volume 19:Number 6(2014:Dec.) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder. (26th February 2014) Authors: Soares, Claudio N.; Endicott, Jean; Boucher, Matthieu; Fayyad, Rana S.; Guico-Pabia, Christine J. Journal: CNS spectrums Issue: Volume 19:Number 6(2014:Dec.) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder. Issue 5 (October 2017) Authors: Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; Meier, Ellen; Prieto, Rita; Pappadopulos, Elizabeth; Mackell, Joan; Boucher, Matthieu Journal: Journal of clinical psychopharmacology Issue: Volume 37:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗